WallStreetZenWallStreetZen

NASDAQ: ACHL
Achilles Therapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ACHL stock forecasts and price targets.

Forecast return on equity

Is ACHL forecast to generate an efficient return?

Company
-66.92%
Industry
232.65%
Market
63.8%
ACHL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACHL forecast to generate an efficient return on assets?

Company
-56.26%
Industry
34.32%
ACHL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACHL earnings per share forecast

What is ACHL's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.93
Avg 2 year Forecast
-$1.22
Avg 3 year Forecast
-$1.43

ACHL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACHL$1.16N/AN/A
IVVD$0.40$7.52+1,783.96%Strong Buy
ICCC$5.33N/AN/A
TNXP$0.26$11.00+4,196.88%Strong Buy
ALVR$0.41N/AN/A
View Top Biotech Stocks

Achilles Therapeutics Stock Forecast FAQ

What is ACHL's earnings growth forecast for 2025-2027?

(NASDAQ: ACHL) Achilles Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.16%.

Achilles Therapeutics's earnings in 2025 is -$66,879,000.On average, 2 Wall Street analysts forecast ACHL's earnings for 2025 to be -$38,207,142, with the lowest ACHL earnings forecast at -$71,484,330, and the highest ACHL earnings forecast at -$4,929,954. On average, 1 Wall Street analyst forecast ACHL's earnings for 2026 to be -$50,121,197, with the lowest ACHL earnings forecast at -$50,121,197, and the highest ACHL earnings forecast at -$50,121,197.

In 2027, ACHL is forecast to generate -$58,748,616 in earnings, with the lowest earnings forecast at -$58,748,616 and the highest earnings forecast at -$58,748,616.

If you're new to stock investing, here's how to buy Achilles Therapeutics stock.

What is ACHL's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ACHL) forecast ROE is -66.92%, which is considered weak.

What is ACHL's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ACHL) Achilles Therapeutics's current Earnings Per Share (EPS) is -$1.65. On average, analysts forecast that ACHL's EPS will be -$0.93 for 2025, with the lowest EPS forecast at -$1.74, and the highest EPS forecast at -$0.12. On average, analysts forecast that ACHL's EPS will be -$1.22 for 2026, with the lowest EPS forecast at -$1.22, and the highest EPS forecast at -$1.22. In 2027, ACHL's EPS is forecast to hit -$1.43 (min: -$1.43, max: -$1.43).

What is ACHL's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ACHL) forecast ROA is -56.26%, which is lower than the forecast US Biotechnology industry average of 34.32%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.